Current perspectives in Bietti crystalline dystrophy

GP García-García,1 M Martínez-Rubio,1 MA Moya-Moya,1 JJ Pérez-Santonja,1 J Escribano2,31Department of Ophthalmology, General University Hospital of Alicante, Alicante 03010, Spain; 2Cooperative Research Network on Ophthalmology (OftaRed), Visual and Life Q...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: García-García GP, Martínez-Rubio M, Moya-Moya MA, Pérez-Santonja JJ, Escribano J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/88999669c742478e94951beebaa04277
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:88999669c742478e94951beebaa04277
record_format dspace
spelling oai:doaj.org-article:88999669c742478e94951beebaa042772021-12-02T06:30:20ZCurrent perspectives in Bietti crystalline dystrophy1177-5483https://doaj.org/article/88999669c742478e94951beebaa042772019-07-01T00:00:00Zhttps://www.dovepress.com/current-perspectives-in-bietti-crystalline-dystrophy-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483GP García-García,1 M Martínez-Rubio,1 MA Moya-Moya,1 JJ Pérez-Santonja,1 J Escribano2,31Department of Ophthalmology, General University Hospital of Alicante, Alicante 03010, Spain; 2Cooperative Research Network on Ophthalmology (OftaRed), Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain; 3Laboratory of Human Molecular Genetics, Medicine Faculty/Research Institute on Neurological Disabilities (IDINE), University of Castilla La-Mancha, Albacete 02006, SpainAbstract: Bietti crystalline dystrophy (BCD) is a rare-inherited disease caused by mutations in the CYP4V2 gene and characterized by the presence of multiple shimmering yellow-white deposits in the posterior pole of the retina in association with atrophy of the retinal pigment epithelium (RPE) and chorioretinal atrophy. The additional presence of glittering dots located at the corneal limbus is also a frequent finding. The CYP4V2 protein belongs to the cytochrome P450 subfamily 4 and is mainly expressed in the retina and the RPE and less expressed in the cornea. The disease has its metabolic origin in the diminished transformation of fatty acid substrates into n-3 polyunsaturated fatty acids due to a dysregulation of the lipid metabolism. In this review, we provide updated insights on clinical and molecular characteristics of BCD including underlying mechanisms of BCD, genetic diagnosis, progress in the identification of causative genetic and epigenetic factors, available techniques of exploration and development of novel therapies. This information will help clinicians to improve accuracy of BCD diagnosis, providing the patient reliable information regarding prognosis and clinical prediction of the disease course.Keywords: Bietti crystalline dystrophy, CYP4V2 gene, corneal deposits, retinal depositsGarcía-García GPMartínez-Rubio MMoya-Moya MAPérez-Santonja JJEscribano JDove Medical PressarticleBietti crystalline dystrophyCYP4V2 genecorneal depositsretinal deposits.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 1379-1399 (2019)
institution DOAJ
collection DOAJ
language EN
topic Bietti crystalline dystrophy
CYP4V2 gene
corneal deposits
retinal deposits.
Ophthalmology
RE1-994
spellingShingle Bietti crystalline dystrophy
CYP4V2 gene
corneal deposits
retinal deposits.
Ophthalmology
RE1-994
García-García GP
Martínez-Rubio M
Moya-Moya MA
Pérez-Santonja JJ
Escribano J
Current perspectives in Bietti crystalline dystrophy
description GP García-García,1 M Martínez-Rubio,1 MA Moya-Moya,1 JJ Pérez-Santonja,1 J Escribano2,31Department of Ophthalmology, General University Hospital of Alicante, Alicante 03010, Spain; 2Cooperative Research Network on Ophthalmology (OftaRed), Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain; 3Laboratory of Human Molecular Genetics, Medicine Faculty/Research Institute on Neurological Disabilities (IDINE), University of Castilla La-Mancha, Albacete 02006, SpainAbstract: Bietti crystalline dystrophy (BCD) is a rare-inherited disease caused by mutations in the CYP4V2 gene and characterized by the presence of multiple shimmering yellow-white deposits in the posterior pole of the retina in association with atrophy of the retinal pigment epithelium (RPE) and chorioretinal atrophy. The additional presence of glittering dots located at the corneal limbus is also a frequent finding. The CYP4V2 protein belongs to the cytochrome P450 subfamily 4 and is mainly expressed in the retina and the RPE and less expressed in the cornea. The disease has its metabolic origin in the diminished transformation of fatty acid substrates into n-3 polyunsaturated fatty acids due to a dysregulation of the lipid metabolism. In this review, we provide updated insights on clinical and molecular characteristics of BCD including underlying mechanisms of BCD, genetic diagnosis, progress in the identification of causative genetic and epigenetic factors, available techniques of exploration and development of novel therapies. This information will help clinicians to improve accuracy of BCD diagnosis, providing the patient reliable information regarding prognosis and clinical prediction of the disease course.Keywords: Bietti crystalline dystrophy, CYP4V2 gene, corneal deposits, retinal deposits
format article
author García-García GP
Martínez-Rubio M
Moya-Moya MA
Pérez-Santonja JJ
Escribano J
author_facet García-García GP
Martínez-Rubio M
Moya-Moya MA
Pérez-Santonja JJ
Escribano J
author_sort García-García GP
title Current perspectives in Bietti crystalline dystrophy
title_short Current perspectives in Bietti crystalline dystrophy
title_full Current perspectives in Bietti crystalline dystrophy
title_fullStr Current perspectives in Bietti crystalline dystrophy
title_full_unstemmed Current perspectives in Bietti crystalline dystrophy
title_sort current perspectives in bietti crystalline dystrophy
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/88999669c742478e94951beebaa04277
work_keys_str_mv AT garciagarciagp currentperspectivesinbietticrystallinedystrophy
AT martinezrubiom currentperspectivesinbietticrystallinedystrophy
AT moyamoyama currentperspectivesinbietticrystallinedystrophy
AT perezsantonjajj currentperspectivesinbietticrystallinedystrophy
AT escribanoj currentperspectivesinbietticrystallinedystrophy
_version_ 1718399883708203008